| 000 | 01636 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250511210834.0 | ||
| 264 | 0 | _c19910830 | |
| 008 | 199108s 0 0 eng d | ||
| 022 | _a0003-4819 | ||
| 024 | 7 |
_a10.7326/0003-4819-115-5-350 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSninsky, C A | |
| 245 | 0 | 0 |
_aOral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study. _h[electronic resource] |
| 260 |
_bAnnals of internal medicine _cSep 1991 |
||
| 300 |
_a350-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAminosalicylic Acids _xadverse effects |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMesalamine |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aStatistics as Topic |
| 650 | 0 | 4 | _aTablets, Enteric-Coated |
| 700 | 1 | _aCort, D H | |
| 700 | 1 | _aShanahan, F | |
| 700 | 1 | _aPowers, B J | |
| 700 | 1 | _aSessions, J T | |
| 700 | 1 | _aPruitt, R E | |
| 700 | 1 | _aJacobs, W H | |
| 700 | 1 | _aLo, S K | |
| 700 | 1 | _aTargan, S R | |
| 700 | 1 | _aCerda, J J | |
| 773 | 0 |
_tAnnals of internal medicine _gvol. 115 _gno. 5 _gp. 350-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7326/0003-4819-115-5-350 _zAvailable from publisher's website |
| 999 |
_c1869228 _d1869228 |
||